Chao Yining, Gu Tianwei, Zhang Zhou, Wu Tianyu, Wang Jin, Bi Yan
Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, China.
J Diabetes. 2023 Oct;15(10):838-852. doi: 10.1111/1753-0407.13456. Epub 2023 Aug 16.
Diabetes poses severe global public health problems and places heavy burdens on the medical and economic systems of society. Type 2 diabetes (T2D) accounts for 90% of these cases. Diabetes also often accompanies serious complications that threaten multiple organs such as the brain, eyes, kidneys, and the cardiovascular system. MicroRNAs (miRNAs) carried by extracellular vesicles (EV-miRNAs) are considered to mediate cross-organ and cross-cellular communication and have a vital role in the pathophysiology of T2D. They also offer promising sources of diabetes-related biomarkers and serve as effective therapeutic targets. Here, we briefly reviewed studies of EV-miRNAs in T2D and related complications. Specially, we innovatively explore the targeting nature of miRNA action due to the target specificity of vesicle binding, aiding mechanism understanding as well as the detection and treatment of diseases.
糖尿病给全球带来了严重的公共卫生问题,给社会的医疗和经济系统造成了沉重负担。其中,2型糖尿病(T2D)占这些病例的90%。糖尿病还常常伴有严重并发症,威胁大脑、眼睛、肾脏和心血管系统等多个器官。细胞外囊泡携带的微小RNA(EV-miRNAs)被认为介导跨器官和跨细胞通讯,在T2D的病理生理学中起着至关重要的作用。它们也是糖尿病相关生物标志物的有前景来源,并可作为有效的治疗靶点。在此,我们简要回顾了EV-miRNAs在T2D及相关并发症方面的研究。特别地,由于囊泡结合的靶标特异性,我们创新性地探索了miRNA作用的靶向性质,有助于理解疾病机制以及疾病的检测和治疗。